user Sign In

QYResearch Account

Manage your Account and Access Personalized Content.

Sign in

Create Account with us

Manage your Account and Access Personalized Content.

Sign Up
       
  
×

Global Oral Dissolvable Films Forecast & Opportunities 2019

Published Date: 2019-02-11   |   Pages: 99   |   Tables: 107   | Report Id: 991512   | Hits: 4 |   Pharma & Healthcare



Oral drug delivery is an essential part of drug delivery and pharmaceutical industry. People with a condition called dysphagia (difficulty in swallowing) require oral administration of drugs. Thus, oral thin film medication are developed for swift oral administration of drugs.

To improve patient compliance various types of vaccines and hormones are developed by the market players.

Technological advancement in drug discovery and development processes, less bio-availability of solid drugs, and inaccurate dosage by liquid formulations is expected to boost the market growth for oral dissolvable films market.

However, challenges related to drug development and massive research investment required for creation of simple and novel formulation is expected to hinder the market.

The global Oral Dissolvable Films market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Oral Dissolvable Films volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oral Dissolvable Films market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

MonoSol

Tesa Labtec

IntelGenX

BioDelivery Sciences

Cynapsus Therapeutics

FFT Medical

Innoteq

Acadia Pharmaceuticals

Neuroderm

Transition Therapeutics

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Oral Dispersible

Sublingual

Buccal

Segment by Application

Pharma & Healthcare

Others

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

QYR Clients

More Clients...